North American Endoscopes Market Research Report
- Report Code: EN 1001
- Publish Date: Upcoming
The North American endoscope market, mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures, was valued at $4.9 billion in 2013 and is expected to reach $6.8 billion by 2018, growing at a CAGR of 6.8% during the forecast period.
The report on the North American market for endoscopes analyzes the market of under four segments: rigid endoscopes, flexible endoscopes, surgical endoscopes, and capsule endoscopes. With a market value of $1.2 billion and $0.8 billion respectively, surgical and flexible endoscopes segments have been contributing 41.7% and 26.0% to the global market. All these segments experienced a positive growth with an increased awareness of patients and physicians towards the usage and reception of new endoscopy technologies due to the numerous advantages offered by these devices.
The demand for endoscopes has increased significantly, largely because of patients’ preference for minimally invasive surgeries. Endoscopic procedures are low-risk procedures and are easily covered by health insurance. A pivotal factor that propels the growth of the endoscopy market is the rapid rise in the number of elderly people who are prone to orthopedic, gastrointestinal, and ophthalmic diseases, as well as cancer. As per the World Health Organization (WHO), between 2000 and 2050, the proportion of the world's population that is aged 60 years will double from about 11% to 22%. This aging population is the main end user of knee-hip implants, bariatric surgeries, gastrointestinal endoscopy, and colonoscopy procedures. With the growing number of elderly people, age-related ailments are also expected to rise sharply, thus propelling the demand and consumption of endoscopy devices concomitantly.
The number of people in the world who are obese or overweight has topped 2.1 billion, up from 875 million in 1980. Furthermore, approximately 7 million people in the United States have some symptoms of Gastroesophageal Reflux Disorder (GERD). Primary or secondary GERD diagnosis increased by an unprecedented 216% or from a total of 995,402 individuals diagnosed in 1998 to 3,141,965 in 2005. 4.2% of all people hospitalized with GERD in 2005 also had an esophageal disorder. In the United States, 1,150 deaths in 2004 were directly related to a primary diagnosis of GERD. Endoscopic treatments for GERD are newer and are still being studied but are likely to grow in coming years.
North America has the highest share in the global endoscopes market. North America and Europe are both likely to witness a demand for endoscopies as a result of technological advancements as well as improved reimbursement status in both geographies. Rapidly aging population, increased obesity rates, and growing incidence of associated disease are some of the major factors driving the North American market.
The high incidence of colon cancer combined with increased reimbursement coverage for colorectal cancer screening is likely to fuel the demand for endoscopy instruments required for the screening of cancer and are likely to drive market in U.S. Physician bonuses are likely to drive laparoscopic surgeries in Canada.
According to Centers for Disease Control and Prevention 52,045 people in the United States died from colorectal cancer, including 27,073 men and 24,972 women. In 2014 about 136,830 people are predicted to be diagnosed with colorectal cancer in the US, and about 50,310 people are predicted to die of the disease. In both men and women, colorectal cancer is the third most commonly diagnosed cancer and the third leading cause of cancer death.
This report provides an extensive competitive landscape of companies operating in the North American market for endoscopes. The key players in this market are Stryker Corporation, Ethicon Endo-Surgery, Inc., Olympus Corporation, Covidien plc, Arthrex, Inc., Smiths Group plc, Aesculap, Inc., ConMed Corporation, Richard Wolf GmbH, Hoya Corporation, and Fujifilm Holdings Corporation.
The details of segment and country-specific company shares, news and deals, mergers and acquisitions, segment-specific pipeline products, product approvals, and product recalls of the major companies have also been covered in the report.
Report Customization Options
Along with market data, you can also customize MMM offerings that are in keeping with your company’s specific needs. Customize your report on the North American market for endoscopes to get an insight into all-inclusive industry standards and a deep-dive analysis of the following considerations:
Product Analysis
- Usage pattern (in-depth trend analysis) of endoscopes (segment wise)
- Product matrix which gives a detailed comparison of the product portfolio of each company mapped at country and sub-segment level
- End-user adoption rate analysis of endoscopes (segment wise and country wise)
- Comprehensive coverage of product approvals, pipeline products, and product recalls
Epidemiology Data
- Country-specific prevalence of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Country-specific patient pool of cancer, gastrointestinal tract disorders, gastroesophageal reflux disorder (GERD), and gynecological disorders
- Disease progression (pattern analysis)
Procedure Volume Data
- Different types of endoscopy procedures performed annually in each country tracked till sub- segment level
- Number of abdominal, gastrointestinal, interior of joints, gynecology, bronchology, and large and small intestinal procedures performed in each country
Surgeon/Physician Perception Analysis
- Fast turnaround analysis of surgeons’ response to market events and trends
- Surgeons’ opinion about products from different companies
- Surgeons’ qualitative inputs on epidemiology data
Brand/ Product Perception Matrix
- Comprehensive study of customers perception and behavior through our inbuilt social connection tool checking the virality and tonality of blogs
- Analysis of overall brand usage and familiarity and brand advocacy distribution (detractor/neutral/familiar)
Pricing Trends
- Cost analysis of endoscopes in various North American countries
- Investment in abdominal, gastrointestinal, interior of joints, gynecology, bronchology, and large and small intestinal procedures in major countries
Competitive Intelligence
- Company share analysis of the top players in the North American market
- Crucial developments and strategies of companies inculcating endoscopes in their portfolio
Alternative Products: Impact Analysis
MMM’s Healthcare Decision Making Quadrant: It is an innovative and useful quadrant for vendors who wish to analyze potential growth markets based on parameters like patient dynamics (patient pool, epidemiology of disease, and preference towards surgeries/alternative therapies) and macroeconomic indicators (number of hospitals and cancer centers, reimbursement scenario, diagnosis rate, treatment rate, and healthcare expenditure).
Please fill in the form below to receive a free copy of the Summary of this Report
Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
| PRODUCT TITLE | PUBLISHED | |
|---|---|---|
|
|
North American Endoscopy Devices Market The North American Endoscopy Devices Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $11.9 billion in 2013 and expected to be $16.2 billion by 2018, growing at a CAGR of 6.4%.The Endoscopy Devices Market analyzes the market segments such as Endoscopes, Endoscopic Visualization System, Endoscopic Accessories, Electronic Endoscopic Instruments and Mechanical Endoscopic Instruments. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
European Endoscopy Devices Market The European Endoscopy Devices Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $7.7 billion in 2013 and expected to be $9.9 billion by 2018, growing at a CAGR of 5.2%.The Endoscopy Devices Market analyzes the market segments such as Endoscopes, Endoscopic Visualization System, Endoscopic Accessories, Electronic Endoscopic Instruments and Mechanical Endoscopic Instruments. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
|
|
Asian Endoscopy Devices Market The Asian Endoscopy Devices Market is mainly driven by favorable reimbursements in select geographies, growing aging population, and increasing prevalence/incidence of diseases requiring endoscopy procedures. It was pegged at $7.1 billion in 2013 and expected to be $10 billion by 2018, growing at a CAGR of 7.1%.The Endoscopy Devices Market analyzes the market segments such as Endoscopes, Endoscopic Visualization System, Endoscopic Accessories, Electronic Endoscopic Instruments and Mechanical Endoscopic Instruments. The prominent players are Stryker Corporation, Ethicon Endo-Surgery, Inc, Olympus Corporation, Covidien Plc, Boston Scientific, Arthrex, Inc., Smiths Group, Aesculap, Inc, Karl Storz, ConMed, Richard Wolf GmbH, HOYA CORPORATION and Fujifilm Holdings Corporation. |
Upcoming |
